Il trattamento dell'iperparatiroidismo primitivo asintomatico: Una controversia ancora aperta

Translated title of the contribution: The management of the patient with asymptomatic primitive hyperparathyroidism: One still open controversy

Carmela Sferrazza, Daniela Avila, Nicola Napoli, Stefania Sferrazza, Giuseppe Rotolo, Giovam Battista Rini

Research output: Contribution to journalArticle

Abstract

Primitive hyperparathyroidism (pHPT) is the most common form of hyperparathyroidism. The asintomatic form (apHPT) accounts for 75-80 percent of cases and is characterized by minimal symptoms secondary to high levels of calcemia. Bisphosphonate and calciomimetic drugs represent a potential alternative to the surgery in the treatment of apHPT patients, but at the present there are not guidelines on medical therapy in the management of these kind of patients.

Original languageItalian
Pages (from-to)345-348
Number of pages4
JournalRecenti Progressi in Medicina
Volume97
Issue number6
Publication statusPublished - Jun 2006

Fingerprint

Hyperparathyroidism
Diphosphonates
Hypercalcemia
Guidelines
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sferrazza, C., Avila, D., Napoli, N., Sferrazza, S., Rotolo, G., & Rini, G. B. (2006). Il trattamento dell'iperparatiroidismo primitivo asintomatico: Una controversia ancora aperta. Recenti Progressi in Medicina, 97(6), 345-348.

Il trattamento dell'iperparatiroidismo primitivo asintomatico : Una controversia ancora aperta. / Sferrazza, Carmela; Avila, Daniela; Napoli, Nicola; Sferrazza, Stefania; Rotolo, Giuseppe; Rini, Giovam Battista.

In: Recenti Progressi in Medicina, Vol. 97, No. 6, 06.2006, p. 345-348.

Research output: Contribution to journalArticle

Sferrazza, C, Avila, D, Napoli, N, Sferrazza, S, Rotolo, G & Rini, GB 2006, 'Il trattamento dell'iperparatiroidismo primitivo asintomatico: Una controversia ancora aperta', Recenti Progressi in Medicina, vol. 97, no. 6, pp. 345-348.
Sferrazza C, Avila D, Napoli N, Sferrazza S, Rotolo G, Rini GB. Il trattamento dell'iperparatiroidismo primitivo asintomatico: Una controversia ancora aperta. Recenti Progressi in Medicina. 2006 Jun;97(6):345-348.
Sferrazza, Carmela ; Avila, Daniela ; Napoli, Nicola ; Sferrazza, Stefania ; Rotolo, Giuseppe ; Rini, Giovam Battista. / Il trattamento dell'iperparatiroidismo primitivo asintomatico : Una controversia ancora aperta. In: Recenti Progressi in Medicina. 2006 ; Vol. 97, No. 6. pp. 345-348.
@article{5dc1e5918aa344f1b6dcd084623d377d,
title = "Il trattamento dell'iperparatiroidismo primitivo asintomatico: Una controversia ancora aperta",
abstract = "Primitive hyperparathyroidism (pHPT) is the most common form of hyperparathyroidism. The asintomatic form (apHPT) accounts for 75-80 percent of cases and is characterized by minimal symptoms secondary to high levels of calcemia. Bisphosphonate and calciomimetic drugs represent a potential alternative to the surgery in the treatment of apHPT patients, but at the present there are not guidelines on medical therapy in the management of these kind of patients.",
keywords = "Bisphosphonate drugs, Metabolic bone diseases, Primitive hyperparathyroidism",
author = "Carmela Sferrazza and Daniela Avila and Nicola Napoli and Stefania Sferrazza and Giuseppe Rotolo and Rini, {Giovam Battista}",
year = "2006",
month = "6",
language = "Italian",
volume = "97",
pages = "345--348",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "6",

}

TY - JOUR

T1 - Il trattamento dell'iperparatiroidismo primitivo asintomatico

T2 - Una controversia ancora aperta

AU - Sferrazza, Carmela

AU - Avila, Daniela

AU - Napoli, Nicola

AU - Sferrazza, Stefania

AU - Rotolo, Giuseppe

AU - Rini, Giovam Battista

PY - 2006/6

Y1 - 2006/6

N2 - Primitive hyperparathyroidism (pHPT) is the most common form of hyperparathyroidism. The asintomatic form (apHPT) accounts for 75-80 percent of cases and is characterized by minimal symptoms secondary to high levels of calcemia. Bisphosphonate and calciomimetic drugs represent a potential alternative to the surgery in the treatment of apHPT patients, but at the present there are not guidelines on medical therapy in the management of these kind of patients.

AB - Primitive hyperparathyroidism (pHPT) is the most common form of hyperparathyroidism. The asintomatic form (apHPT) accounts for 75-80 percent of cases and is characterized by minimal symptoms secondary to high levels of calcemia. Bisphosphonate and calciomimetic drugs represent a potential alternative to the surgery in the treatment of apHPT patients, but at the present there are not guidelines on medical therapy in the management of these kind of patients.

KW - Bisphosphonate drugs

KW - Metabolic bone diseases

KW - Primitive hyperparathyroidism

UR - http://www.scopus.com/inward/record.url?scp=33745491277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745491277&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:33745491277

VL - 97

SP - 345

EP - 348

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 6

ER -